Revolutionize the Development & Delivery of Neurological Gene Therapies
Returning this year as a digital meeting with an agenda designed with the field’s thought-leaders including Pfizer, Biogen, Voyager and Novartis, the 2nd Annual Gene Therapy for Neurological Disorders is the industry’s only meeting dedicated to solving your translational drug development challenges, enabling you to accelerate the development of your neurological gene therapy candidate.
Don’t get left behind. Attend this meeting to transform gene therapy delivery to the CNS, optimize translational modelling approaches and discover targeted, efficacious, and safe vectors to revolutionize the treatment of neurological disorders.
To learn more about Gene Therapy for Neurological Disorders please click here: https://ter.li/c610sy